3CTH | pdb_00003cth

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.273 (Depositor), 0.230 (DCC) 
  • R-Value Work: 
    0.207 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 
    0.212 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 3CTH

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors

Cai, Z.-W.Wei, D.Schroeder, G.M.Cornelius, L.A.Kim, K.Chen, X.-T.Schmidt, R.J.Williams, D.K.Tokarski, J.S.An, Y.Sack, J.S.Manne, V.Kamath, A.Zhang, Y.Marathe, P.Hunt, J.T.Lombardo, L.J.Fargnoli, J.Borzilleri, R.M.

(2008) Bioorg Med Chem Lett 18: 3224-3229

  • DOI: https://doi.org/10.1016/j.bmcl.2008.04.047
  • Primary Citation Related Structures: 
    3CTH, 3CTJ

  • PubMed Abstract: 

    A series of acylurea analogs derived from pyrrolopyridine and aminopyridine scaffolds were identified as potent inhibitors of Met kinase activity. The SAR at various positions of the two kinase scaffolds was investigated. These studies led to the discovery of compounds 3b and 20b, which demonstrated favorable pharmacokinetic properties in mice and significant antitumor activity in a human gastric carcinoma xenograft model.


  • Organizational Affiliation
    • Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, NJ 08543-4000, USA. zhenwei.cai@bms.com

Macromolecule Content 

  • Total Structure Weight: 35.83 kDa 
  • Atom Count: 2,461 
  • Modeled Residue Count: 295 
  • Deposited Residue Count: 314 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Hepatocyte growth factor receptor314Homo sapiensMutation(s): 3 
Gene Names: MET
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for P08581 (Homo sapiens)
Explore P08581 
Go to UniProtKB:  P08581
PHAROS:  P08581
GTEx:  ENSG00000105976 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08581
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
319

Query on 319



Download:Ideal Coordinates CCD File
B [auth A]N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
C20 H16 F2 N4 O3
USBSTVPJNQLYEM-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
319 BindingDB:  3CTH IC50: 35 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.273 (Depositor), 0.230 (DCC) 
  • R-Value Work:  0.207 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 0.212 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 42.752α = 90
b = 47.637β = 90
c = 152.471γ = 90
Software Package:
Software NamePurpose
BUSTER-TNTrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2008-06-10 
  • Deposition Author(s): Sack, J.

Revision History  (Full details and data files)

  • Version 1.0: 2008-06-10
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-10-20
    Changes: Database references, Derived calculations
  • Version 1.3: 2024-02-21
    Changes: Data collection